A detailed history of Caisse De Depot Et Placement Du Quebec transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Caisse De Depot Et Placement Du Quebec holds 2,282,297 shares of BMY stock, worth $133 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
2,282,297
Previous 1,968,175 15.96%
Holding current value
$133 Million
Previous $81.7 Million 44.5%
% of portfolio
0.24%
Previous 0.2%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $12.5 Million - $16.3 Million
314,122 Added 15.96%
2,282,297 $118 Million
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $11.3 Million - $14.9 Million
-280,686 Reduced 12.48%
1,968,175 $81.7 Million
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $34.6 Million - $39.2 Million
-721,046 Reduced 24.28%
2,248,861 $122 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $19.8 Million - $23.6 Million
-408,707 Reduced 12.1%
2,969,907 $152 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $67.9 Million - $75.9 Million
-1,173,244 Reduced 25.78%
3,378,614 $196 Million
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $63.3 Million - $70.2 Million
-992,983 Reduced 17.91%
4,551,858 $291 Million
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $52.4 Million - $59.4 Million
-797,173 Reduced 12.57%
5,544,841 $384 Million
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $35 Million - $41.5 Million
-511,404 Reduced 7.46%
6,342,014 $456 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $201,001 - $119 Million
1,546,164 Added 29.13%
6,853,418 $487 Million
Q2 2022

Aug 12, 2022

BUY
$72.62 - $79.98 $219 Million - $241 Million
3,011,581 Added 131.19%
5,307,254 $409 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $87.2 Million - $105 Million
1,418,497 Added 161.71%
2,295,673 $168 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $4.69 Million - $5.46 Million
-87,400 Reduced 9.06%
877,176 $54.7 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $3.21 Million - $3.76 Million
54,300 Added 5.97%
964,576 $57.1 Million
Q2 2021

Aug 13, 2021

BUY
$61.91 - $67.42 $28.1 Million - $30.6 Million
453,603 Added 99.33%
910,276 $60.8 Million
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $244,362 - $274,835
-4,118 Reduced 0.89%
456,673 $28.8 Million
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $25.5 Million - $28.9 Million
-442,382 Reduced 48.98%
460,791 $28.6 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $21.3 Million - $23.6 Million
370,200 Added 69.46%
903,173 $54.5 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $274 - $320
-5 Reduced -0.0%
532,973 $31.3 Million
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $12.8 Million - $18.7 Million
276,837 Added 108.08%
532,978 $29.7 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $3.42 Million - $4.46 Million
69,460 Added 37.21%
256,141 $16.4 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $3.29 Million - $3.91 Million
77,007 Added 70.21%
186,681 $9.47 Million
Q2 2019

Aug 09, 2019

SELL
$44.62 - $49.34 $11.4 Million - $12.6 Million
-255,500 Reduced 69.97%
109,674 $4.97 Million
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $13.2 Million - $15.7 Million
-292,400 Reduced 44.47%
365,174 $17.4 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $12.5 Million - $16.3 Million
257,300 Added 64.28%
657,574 $34.2 Million
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $976,863 - $1.1 Million
-17,700 Reduced 4.23%
400,274 $24.8 Million
Q2 2018

Aug 13, 2018

SELL
$50.53 - $62.98 $2.11 Million - $2.63 Million
-41,800 Reduced 9.09%
417,974 $23.1 Million
Q1 2018

May 14, 2018

SELL
$59.92 - $68.98 $1.39 Million - $1.6 Million
-23,200 Reduced 4.8%
459,774 $29.1 Million
Q4 2017

Feb 13, 2018

SELL
$59.94 - $65.35 $5.2 Million - $5.67 Million
-86,800 Reduced 15.23%
482,974 $29.6 Million
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $31.5 Million - $36.3 Million
569,774
569,774 $36.5 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Caisse De Depot Et Placement Du Quebec Portfolio

Follow Caisse De Depot Et Placement Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.